|
Volumn 20, Issue 6, 2001, Pages 867-882
|
Heterogeneity in phase I clinical trials: Prior elicitation and computation using the continual reassessment method
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
CANCER;
CONTROLLED STUDY;
COVARIANCE;
DOSE RESPONSE;
MAXIMUM TOLERATED DOSE;
PARAMETER;
PHASE 1 CLINICAL TRIAL;
POPULATION;
PREDICTION;
STATISTICAL ANALYSIS;
TECHNIQUE;
ALGORITHMS;
CLINICAL TRIALS, PHASE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
INDIVIDUALITY;
LIKELIHOOD FUNCTIONS;
MALE;
MARKOV CHAINS;
MAXIMUM TOLERATED DOSE;
MODELS, BIOLOGICAL;
MONTE CARLO METHOD;
|
EID: 0035970739
PISSN: 02776715
EISSN: None
Source Type: Journal
DOI: 10.1002/sim.701 Document Type: Article |
Times cited : (34)
|
References (11)
|